Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesATG plus Cyclosporine Reduces All-Cause Mortality in Patients with Severe Aplastic Anemia - Systematic Review and Meta-Analysis
Acta Haematologica, 02/26/09
Gafter-Gvili A et al. - The combination of both drugs should be considered the gold standard only for patients with severe aplastic anemia.
Related Articles
Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia
European Journal of Haematology, 12/11/09
Relevance Score: 67%
Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT
Bone Marrow Transplantation, 11/19/09
Relevance Score: 67%
Hepatitis-associated Aplastic Anemia Presenting as a Familial Bone Marrow Failure Syndrome
Journal of Pediatric Hematology/Oncology, 11/30/09
Relevance Score: 66%
Downregulation of GATA-2 and overexpression of adipogenic gene-PPARgamma in mesenchymal stem cells from patients with aplastic anemia
Experimental Hematology, 11/25/09
Relevance Score: 66%
Liver transplantation for fulminant hepatic failure in infancy
Pediatric Transplantation, 11/04/09
Relevance Score: 64%
Today in Anemia/Polycythemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease
European Journal of Haematology, 12/15/09
Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA
British Journal of Haematology, 12/14/09
Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients
Clinical and Translational Oncology, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor